TY  - JOUR
AU  - García-Cremades Mira, María
AU  - Solans, Belén P.
AU  - Hughes, Emma 
AU  - Ernest, Jacqueline P. 
AU  - Wallender, Erika 
AU  - Aweeka, Francesca 
AU  - Luetkemeyer, Anne F. 
AU  - Savic, Radojka M. 
PY  - 2020
DO  - 10.1002/cpt.1856
SN  - 0009-9236
UR  - https://hdl.handle.net/20.500.14352/101030
T2  - Clinical Pharmacology & Therapeutics
AB  - Hydroxychloroquine (HCQ) is a promising candidate for Coronavirus disease of 2019 (COVID‐19) treatment. The optimal dosing of HCQ is unknown. Our goal was to integrate historic and emerging pharmacological and toxicity data to understand safe and...
LA  - eng
M2  - 253
PB  - Wiley
TI  - Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing
TY  - journal article
VL  - 108
ER  -